Clara Rodríguez Fernández, Author at Labiotech.eu - Page 13 of 62

About

Traveler, musician, food enthusiast and book worm. Always on the hunt for interesting facts and news.

Articles by Clara Rodríguez Fernández

biotech investment strategies

Interview 31 Oct 2018

Biotech Investment Strategies: How, When and Where to Invest

How, when and where to invest in a biotech company can be essential to the success of both specialized investors and the companies receiving the money. At Refresh Basel, I spoke to Chandra Leo, Partner at the life sciences VC firm HBM Partners, to discuss investment strategies in biotech and his advice for companies seeking […]

October 31, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

Nicole Spit Dutch Design Week

News and Trends 27 Oct 2018

How Will Biotech Influence the Technology of the Future?

Dutch designer Nicole Spit looks into the future of consumer biotech products with a series of speculative design objects being exhibited at the Dutch Design Week. Biotechnology is already revolutionizing healthcare. Soon, it might also take over our daily lives, but are we ready for it? Designer Nicole Spit wants to make us think about […]

October 27, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

NovioSense Glucose Monitor Diabetes

News and Trends 25 Oct 2018

Invisible Eye Glucose Monitor Accurately Measures Sugar Levels

In a small trial in the Netherlands, Dutch firm NovioSense has shown that its device for measuring blood sugar levels through tear fluid is comparable to current continuous glucose sensors. Currently, the standard method for people with diabetes to measure their blood sugar requires finger pricking multiple times per day, which can be painful and […]

October 25, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Microbiotica microbiome live bacteria

News and Trends 24 Oct 2018

UK Microbiome Company Gets Financial Boost for Live Bacterial Therapy

UK-based Microbiotica has received a £4M investment from Seventure’s fund dedicated to investments in the microbiome space. With Seventure coming on board as a new investor, Microbiotica has now raised a total of £12M since its foundation in 2016. The company, a spin-out of the Sanger Institute in Cambridge, seeks to find and exploit precise […]

October 24, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Magnisense cardiovascular blood test

News and Trends 24 Oct 2018

15-Minute Cardiovascular Blood Test to Sell Across Europe

French diagnostics company Magnisense has raised €5M to expand the sales of its emergency tests for heart attack and heart failure, which can be performed at home in just 15 minutes. The diagnostic technology developed by Magnisense, called MiAG, uses magnetic nanoparticles to detect extremely low quantities of cardiovascular biomarkers in the blood. “MiAG allows […]

October 24, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Aelix Therapeutics Gilead Functional HIV Cure

News and Trends 19 Oct 2018

Spanish Biotech Partners Gilead to Develop Functional HIV Cure

AELIX Therapeutics and Gilead will run a clinical trial testing a combination of treatments that has potential to let HIV-infected people ditch lifelong therapy. The trial, which will run in Spain, is planned to start in early 2019 and will recruit around 90 patients in the early stages of HIV infection. After receiving the […]

October 19, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

ADVERTISEMENT

Humira EU patent expired biosimilars

More News! 17 Oct 2018

The EU Patent of the Best Selling Drug Has Expired, What Does it Mean for Biotech?

AbbVie’s Humira, a treatment for inflammatory disease and the world’s best-selling drug, is no longer patent-protected in the EU. Competitors are already taking advantage of it. Humira is an antibody drug, called adalimumab, that has been topping the lists of best-selling drugs for years. Last year alone, it made over €15B in sales worldwide. The […]

October 17, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

microbiome microsoft eagle genomics

News and Trends 15 Oct 2018

Microsoft Signs its First Microbiome Partnership

Microsoft Genomics will work with Cambridge-based Eagle Genomics to scale up its artificial intelligence platform for microbiome research. In recent years, it has become evident that the microbes that inhabit our body are key to our health. The microbiome has been linked to conditions such as diabetes, cancer, Alzheimer’s, multiple sclerosis and many more. However, large-scale studies […]

October 15, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

biotech startup competitions pitch

Best in Biotech 15 Oct 2018

The 7 Best Biotech Startup Competitions in Europe

If you are looking for an opportunity to pitch your startup, look no further. Here’s a guide to the key European events for biotech startup competitions. Taking part in a pitch competition can help a biotech company get a headstart and make its name known to investors and other important players in the biotech industry. […]

October 15, 2018 - 5 minutesmins - By Clara Rodríguez Fernández

Living Instruments Mossphone Music

More News! 14 Oct 2018

Living Instruments: Making Music with Yeast, Moss and Paramecia

These instruments are alive. Yeast, moss and paramecia are behind the unique sounds of Living Instruments, which will be performing a concert in Zurich on October 21st. Instead of strings or windpipes, the sounds of these instruments are generated by living beings. The sound of the ‘yeast organ’ is triggered by the bubbles produced by […]

October 14, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

intelligent fingerprinting drug test

More News! 10 Oct 2018

This Test Can Detect Four Drugs With Just a Fingerprint

The British company Intelligent Fingerprinting has shown that its non-invasive fingerprint drug test can yield results comparable to blood tests in just 10 minutes. The technology, developed at the University of East Anglia, can detect extremely low amounts of amphetamines, cannabis, cocaine and opiate drugs from the sweat of a single fingerprint. The sample is […]

October 10, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Sitryx immunometabolism cancer inflammation

News and Trends 8 Oct 2018

Oxford Biotech Launches with €26M to Target ‘Immunometabolism’

Sitryx has launched today with the goal of treating cancer and inflammatory conditions by targeting the metabolism of immune cells, a promising area of research. The new company has kicked off with a €26M Series A round co-led by two specialized investors, SV Health and Sofinnova Partners. Sitryx also has investment from GSK, with […]

October 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

ADVERTISEMENT